Knockdown of PRKD2 Enhances Chemotherapy Sensitivity in Cervical Cancer via the TP53/CDKN1A Pathway.
Current cancer drug targets（2023）
摘要
In summary, PRKD2 may be a promising therapeutic target to improve the efficacy of chemotherapy.
更多查看译文
关键词
Cervical cancer,PRKD2,TP53/CDKN1A pathway,chemotherapy sensitivity,drug resistance,whole exome sequencing
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要